Intuitive Surgical, Inc.

NASDAQ Global Select
Back to all articles
Somewhat Bearish -25

Intuitive Surgical (NASDAQ:ISRG) Sets New 1-Year Low After Analyst ...

📉 ISRG shares hit a new 52-week low of $346.10 following JPMorgan's price target reduction from $550 to $450.

📊 Deutsche Bank downgraded the stock to 'sell' with a lowered price target of $366, contrasting with recent upgrades from Stifel and Wall Street Zen.

💰 The company reported Q2 revenue of $2.89 billion, an 18.4% year-over-year increase that beat analyst expectations.

📈 EPS reached $2.80 for the quarter, surpassing the consensus estimate of $2.48 by $0.32.

🏦 Institutional ownership is robust at 83.64%, with multiple hedge funds increasing their holdings in Q4.

📉 The stock trades below its 50-day moving average ($412.30) and 200-day moving average ($464.06).

💵 Net margins remain strong at 28.45% with a return on equity of 17.09%.

🔮 Analysts project full-year EPS of $8.61 for the current fiscal year.

🏥 Intuitive Surgical continues to dominate the robotic-assisted surgery market with its da Vinci systems.

Bullish Signals
  • Revenue grew 18.4% year-over-year to $2.89 billion, significantly beating analyst expectations of $2.83 billion.
  • The company reported EPS of $2.80, which exceeded the consensus estimate of $2.48 by $0.32.
  • Net margins remained healthy at 28.45% and return on equity stood at 17.09%.
  • Several institutional investors increased their stakes in Q4, including North Star Investment Management Corp raising its position by 8.5%.
  • Wall Street Zen upgraded the stock from 'hold' to 'buy', and Stifel Nicolaus lowered its target while maintaining a 'buy' rating.
  • The company maintains a dominant market position with high institutional ownership at 83.64%.
Risk Factors
  • JPMorgan Chase lowered its price target from $550 to $450, contributing to the stock hitting a new 52-week low.
  • Deutsche Bank cut its price target to $366 and assigned a 'sell' rating, indicating bearish sentiment among some analysts.
  • The stock is currently trading below both its 50-day simple moving average ($412.30) and 200-day simple moving average ($464.06).
  • Analyst consensus includes seven 'Hold' ratings and one 'Sell' rating alongside the Buy ratings, reflecting mixed outlooks.
Full Analysis
Shares of Intuitive Surgical (NASDAQ:ISRG) hit a new 52-week low around $346 on Monday, driven by JPMorgan Chase lowering its price target from $550 to $450 while maintaining an overweight rating. The stock has faced mixed analyst sentiment recently, with Deutsche Bank cutting its target to $366 and assigning a 'sell' rating, though other firms like Stifel Nicolaus and Wall Street Zen have raised targets or upgraded ratings to 'buy'. Despite the recent price decline, Intuitive Surgical reported strong quarterly financial results on July 16th. The company posted revenue of $2.89 billion, beating estimates by $57 million, with earnings per share (EPS) of $2.80 versus a consensus of $2.48. Revenue grew 18.4% year-over-year, and the firm maintained healthy margins at 28.45% and a return on equity of 17.09%. Institutional ownership remains high at 83.64%, with several hedge funds increasing their stakes in the fourth quarter, including North Star Investment Management Corp which raised its position by 8.5%. The company's market capitalization stands at approximately $124 billion, trading below its 50-day and 200-day moving averages, reflecting current market caution despite solid operational performance.